SI2097079T1 - Modulacija prostaglandin/ciklooksigenaznih metaboličnih poti - Google Patents

Modulacija prostaglandin/ciklooksigenaznih metaboličnih poti

Info

Publication number
SI2097079T1
SI2097079T1 SI200731000T SI200731000T SI2097079T1 SI 2097079 T1 SI2097079 T1 SI 2097079T1 SI 200731000 T SI200731000 T SI 200731000T SI 200731000 T SI200731000 T SI 200731000T SI 2097079 T1 SI2097079 T1 SI 2097079T1
Authority
SI
Slovenia
Prior art keywords
prostaglandin
modulation
metabolic pathways
cyclooxygenase
cyclooxygenase metabolic
Prior art date
Application number
SI200731000T
Other languages
English (en)
Inventor
Ernst Wulfert
Original Assignee
Hunter Fleming Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hunter Fleming Ltd filed Critical Hunter Fleming Ltd
Priority claimed from EP07870407A external-priority patent/EP2097079B1/en
Publication of SI2097079T1 publication Critical patent/SI2097079T1/sl

Links

SI200731000T 2006-11-30 2007-11-29 Modulacija prostaglandin/ciklooksigenaznih metaboličnih poti SI2097079T1 (sl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US86787306P 2006-11-30 2006-11-30
GB0623971A GB0623971D0 (en) 2006-11-30 2006-11-30 Modulation of prostaglandin/cyclooxygenase metabolic pathways
EP07870407A EP2097079B1 (en) 2006-11-30 2007-11-29 Modulation of prostaglandin/cyclooxygenase metabolic pathways
PCT/GB2007/004584 WO2008065408A2 (en) 2006-11-30 2007-11-29 Modulation of prostaglandin/cyclooxygenase metabolic pathways

Publications (1)

Publication Number Publication Date
SI2097079T1 true SI2097079T1 (sl) 2012-10-30

Family

ID=37671641

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200731000T SI2097079T1 (sl) 2006-11-30 2007-11-29 Modulacija prostaglandin/ciklooksigenaznih metaboličnih poti

Country Status (9)

Country Link
CN (1) CN101594861B (sl)
DK (1) DK2097079T3 (sl)
ES (1) ES2390182T3 (sl)
GB (1) GB0623971D0 (sl)
NZ (1) NZ577075A (sl)
PT (1) PT2097079E (sl)
RS (1) RS52453B (sl)
RU (1) RU2448712C2 (sl)
SI (1) SI2097079T1 (sl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI713972B (zh) * 2019-01-14 2020-12-21 大江生醫股份有限公司 改善呼吸道健康之益生菌株及其組合物與用途
TWI692359B (zh) * 2019-02-25 2020-05-01 大江生醫股份有限公司 乳酸菌的代謝產物及其用於護肺的用途
CN111777613A (zh) * 2019-04-03 2020-10-16 中国药科大学 嘧啶二酮并吲哚和吡啶酮并吲哚类化合物的制备及用途
US20220202774A1 (en) * 2019-04-09 2022-06-30 Neurobit Science Co., Ltd. Pharmaceutical composition for prevention or treatment of spinal cord injury or spinal stenosis
CN111394289B (zh) * 2019-12-20 2021-06-11 合肥康诺生物制药有限公司 一种基因工程菌及其应用，生产前列腺素e2的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2363983A (en) * 2000-06-29 2002-01-16 Hunter Fleming Ltd Protection against neuronal damage using 7-hydroxyepiandrosterone
GB2363984A (en) * 2000-06-29 2002-01-16 Hunter Fleming Ltd Protection against neuronal damage using 3-hydroxy-7 -hydroxy steroids and 3-oxo-7 -hydroxy steroids
GB2378898A (en) * 2001-08-14 2003-02-26 Hunter Fleming Ltd Prophylactic and therapeutic use of hydroxysteroids
FR2829697B1 (fr) * 2001-09-14 2004-03-19 Mayoly Spindler Lab Derives 7-hydroxyles et 7-cetoniques des hormones steroides 3 beta-hydroxylees pour le traitement des maladies inflammatoires ou fonctionnelles de l'intestin

Also Published As

Publication number Publication date
GB0623971D0 (en) 2007-01-10
RS52453B (en) 2013-02-28
CN101594861B (zh) 2013-06-12
RU2448712C2 (ru) 2012-04-27
ES2390182T3 (es) 2012-11-07
CN101594861A (zh) 2009-12-02
PT2097079E (pt) 2012-09-24
RU2009124917A (ru) 2011-01-10
DK2097079T3 (da) 2012-10-01
NZ577075A (en) 2012-01-12

Similar Documents

Publication Publication Date Title
IL244116A0 (en) Modulation of the expression of factor 11
IL205536A0 (en) Modulation of factor 7 expression
GB0700194D0 (en) Humanisation of animals
EP2180787A4 (en) MODULATION OF TYPE II DIABETES BY NITRATED FATTY ACIDS
GB2456859B (en) Instruction pre-coding of multiple instruction sets
EP2040730A4 (en) MODULATION OF NKG2D
EP2279410A4 (en) METHODS OF IDENTIFYING ANTI-INFLAMMATORY COMPOUNDS
AP2008004406A0 (en) Methods of managing timberland
PL2133419T3 (pl) Zastosowania beta-dipeptydów cyjanoficyny
IL193271A0 (en) Modulation of bone formation
IL209035A0 (en) Solid states states of o-desmethylvenlafaxine salts
ZA200903584B (en) Modulation of prostaglandin/cyclooxygenase metabolic pathways
IL194775A0 (en) Modulation of lipid rafts
AP2784A (en) Methods of managing timberland
SI2097079T1 (sl) Modulacija prostaglandin/ciklooksigenaznih metaboličnih poti
GB2460009A8 (en) Compounds and methods for the modulation of beta-1integrin function to mediate tissue repair
GB0718870D0 (en) Modulation of RSK
EP2247746A4 (en) METHOD FOR MONITORING METABOLIC WAYS
AP2717A (en) Mono-hydrochloric salts of an inhibitor of histonedeacetylase
IL206333A0 (en) Control of an entity to be controlled by a control entity
GB0815433D0 (en) Manufacture of cast panels
PL383760A1 (pl) Nowe zastosowanie undekan-2-olu
AU2008902214A0 (en) Modulation of Flightness I
GB0712087D0 (en) Modulation of inflamation
TWM300465U (en) Improved structure of shoes